Drug Type Peptide drug conjugates |
Synonyms PL 053, PL053 |
Target |
Action modulators |
Mechanism CYP27A1 modulators(cytochrome P450 family 27 subfamily A member 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioma | Preclinical | China | 29 Feb 2024 |





